Cargando…
The Outcome of Induction Therapy for EBV-Related Hemophagocytic Lymphohistiocytosis: A Model for Risk Stratification
BACKGROUND: Epstein–Barr virus (EBV)–related hemophagocytic lymphohistiocytosis (HLH) is an abnormal inflammation caused by EBV infection, which has high mortality during induction therapy. OBJECTIVES: This study is aimed to build a model to predict the risk of death during induction therapy. METHOD...
Autores principales: | Cui, Tingting, Wang, Jingshi, Wang, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289144/ https://www.ncbi.nlm.nih.gov/pubmed/35860246 http://dx.doi.org/10.3389/fimmu.2022.876415 |
Ejemplares similares
-
Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein–Barr virus (EBV)-related hemophagocytic lymphohistiocytosis
por: Zhao, Yunze, et al.
Publicado: (2020) -
The Treatment Based on Ruxolitinib and Amphotericin B is Effective for Relapsed Leishmaniasis-Related Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
por: Cui, Tingting, et al.
Publicado: (2022) -
Approaching hemophagocytic lymphohistiocytosis
por: Chinnici, Aurora, et al.
Publicado: (2023) -
Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
por: Marsh, Rebecca A.
Publicado: (2018) -
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis
por: Song, Yue, et al.
Publicado: (2023)